HPV相关口咽癌单纯手术治疗死亡预测因素
本研究基于美国国家癌症数据库(NCDB)回顾性分析2010–2014年736例接受单纯手术的HPV相关口咽鳞状细胞癌(HPV+OPSCC)患者,采用单因素和多因素分析及Kaplan-Meier法评估总生存(OS)。多因素分析发现AJCC第8版病理N2 vs pN0、肉眼结外延伸(ENE)、阳性淋巴结比例≥10%及≥5个阳性淋巴结是独立死亡风险因素;AJCC第8版I期患者3年OS达93%,特定低危亚组(pT1-T2、切缘阴性、pN0-N1、≤4个病理淋巴结、无ENE、颈部清扫>20个淋巴结)3年OS达95%。
要点
- AJCC第8版pN2、肉眼ENE、阳性淋巴结比例≥10%及≥5个阳性淋巴结是独立死亡风险因素。
- AJCC第8版I期HPV+OPSCC单纯手术3年OS为93%,5年OS为91%。
- 特定低危亚组(pT1-T2、切缘阴性、pN0-N1、≤4个病理淋巴结、无ENE、>20个淋巴结清扫)3年OS达95%。
核心结论
- 在NCDB数据缺乏细节和可能存在不准确的背景下,AJCC第8版I期HPV+OPSCC单纯手术具有较高的总生存率。
研究设计与样本
- 回顾性分析美国国家癌症数据库(NCDB)2010–2014年736例接受单纯手术的HPV+OPSCC患者,采用单因素和多因素分析及Kaplan-Meier法评估总生存。
主要发现
- 多因素分析显示AJCC第8版pN2 vs pN0死亡风险HR为5.5(P=0.000006),肉眼ENE vs 无ENE的HR为4.9(P<0.02),阳性淋巴结比例≥10%的HR为4.2(P=0.0002),≥5个阳性淋巴结的HR为4.9(P=0.00004)。
- AJCC第8版pN2 vs pN0的3年OS显著更差,但第7版pN2 vs pN0无显著差异。
- 5年OS在切缘阳性 vs 阴性、AJCC第8版II期 vs I期、显微镜下或肉眼ENE vs 无ENE阳性淋巴结中显著更差。
- 523例(71%)AJCC第8版I期患者3年OS为93%,5年OS为91%;283例(38%)满足pT1-T2、切缘阴性、pN0-N1、≤4个病理淋巴结、无ENE且颈部清扫>20个淋巴结的患者3年OS为95%,5年OS为95%。
关键数值与推荐
- AJCC第8版pN2 vs pN0死亡风险HR 5.5(P=0.000006)。
- 肉眼ENE vs 无ENE死亡风险HR 4.9(P<0.02)。
- 阳性淋巴结比例≥10%死亡风险HR 4.2(P=0.0002)。
- ≥5个阳性淋巴结死亡风险HR 4.9(P=0.00004)。
临床怎么用
- 对于AJCC第8版I期HPV+OPSCC,尤其是pT1-T2、pN0-N1、≤4个病理淋巴结、无ENE且切缘阴性的患者,单纯手术可获得较高总生存。
- 存在pN2、肉眼ENE、阳性淋巴结比例≥10%或≥5个阳性淋巴结的患者死亡风险显著升高,需加强术后管理。
局限性
- NCDB数据缺乏细节且可能存在不准确之处。
- 研究为回顾性分析,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Survival outcomes for human papillomavirus-associated oropharynx squamous cell carcinoma (HPV + OPSCC) treated with surgery alone are unclear. To increase understanding, we assessed overall survival (OS) outcomes using the national cancer database (NCDB). METHODS: We conducted a retrospective analysis of OS of 736 NCDB HPV + OPSCC patients who underwent surgery alone from 2010 to 2014 using univariate and multivariate analyses and the Kaplan-Meir method. RESULTS: Multivariable analysis found the following independent risk factors for death: American Joint Commission on Cancer (AJCC) 8th edition pathologic stage(p)N2 versus pN0 disease (hazard ratio [HR], 5.5; P = 0.000006), macroscopic extranodal extension (ENE) versus non-ENE (HR, 4.9; P < 0.02), a positive lymph nodes (LN) percentage of ≥10% (HR, 4.2; P = 0.0002), and five or more positive LNs (HR, 4.9; P = 0.00004). Three-year OS was significantly worse for AJCC 8th edition pN2 versus pN0 but not for 7th edition pN2 versus pN0 disease. Five-year OS was significantly worse for positive versus negative surgical margins, AJCC 8th edition stage II versus I, and either microscopic or macroscopic ENE versus non-ENE positive LNs. For 523 (71%) AJCC 8th edition stage I patients and for 283 (38%) patients who were pT1-T2, with negative margins, pN0-N1, with ≤4 pathologic LNs, without ENE, and with >20 LNs removed during neck dissection, the 3-year OS rates were 93% and 95%, respectively, and the 5-year OS rates were 91% and 95%, respectively. CONCLUSION: In the context of the lack of detail and possible inaccuracies found in the NCDB, surgery alone for AJCC 8th edition stage I HPV + OPSCC, particularly pT1-T2, pN0-N1 with ≤4 pathologic LNs, without ENE, and with negative surgical margins has a high OS. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:E423-E435, 2020.
引用
- Han M, Stanford-Moore GB, Larson AR, et al. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone. Laryngoscope. 2019. PMID: 31675132. doi:10.1002/lary.28344
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。